Peregrine Ventures

Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditional step-wise, reiterative genetic testing.

Blue White Robotics specializes in transforming agriculture through autonomous technology. The company offers a comprehensive platform that enhances both air and ground robot fleets, enabling seamless management and optimization. By leveraging remote sensing and artificial intelligence, Blue White Robotics provides farmers with in-field data to improve productivity and farm economics. Their solutions aim to enhance efficiency and safety while delivering actionable insights that contribute to a return on investment from the outset. The company's focus is on facilitating the easy and safe adoption of autonomy in agriculture, ultimately helping growers maximize productivity and reduce operational costs.

Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditional step-wise, reiterative genetic testing.

BioProtect Ltd. is an international medical device startup. It is primarily engaged in to the business of developing and commercializing biodegradable balloon spacers for the protection of normal tissue during cancer radiation therapy. The company's current focus in the growing radiotherapy spacers market, where its ProSpace balloon spacer (CE marked) has shown superior efficacy and safety in protecting the rectum during radiation therapy for prostate cancer. The company's technology platform of biodegradable implantable balloons suits a wide range of applications for unmet clinical needs. BioProtect was founded in the year 2004 and headquartered in Israel, with subsidiaries in Germany and US.

Althea Medical, established in 2020 in Tel Aviv, Israel, focuses on developing catheter devices for the treatment of patients suffering from pulmonary embolism (PE), including both massive and sub-massive cases. The company's innovative catheter-based solution combines the effectiveness of large bore thrombectomy with a user-friendly delivery mechanism that reduces patient risks. This mechanical clot removal system is designed to efficiently capture and eliminate thrombus, allowing physicians to swiftly access blocked areas and alleviate clot burden, thereby enhancing hemodynamic stability in affected patients.

DataMesh Group delivers integrated payment capabilities and valuable customer insights through bespoke payment and data processing solutions. The company offers financial payment systems software, infrastructure, and data analytics products. It enables retailers to design the customer experience they want to provide by providing the technology they want to deploy and creating a commerce and data hub that merchants, acquirers, card schemes, and third parties can use to achieve better business outcomes.

Nectin Therapeutics Ltd., founded in 2017 and based in Jerusalem, Israel, specializes in the development of monoclonal antibodies targeting members of the Nectin family of receptors and ligands. These antibodies are designed to address immune checkpoint mechanisms that play a crucial role in cancer immunotherapy. By focusing on both solid and hematological malignancies, Nectin Therapeutics aims to create therapies that can overcome the inhibitory pathways utilized by tumors, thereby enhancing the ability of immune cells to eradicate cancer cells. The company's innovative approach seeks to improve patient outcomes in cancer treatment.

Cordio Medical LTD. is a company based in Or Yehuda, Israel, founded in 2013, that specializes in developing a mobile application aimed at monitoring patients with congestive heart failure. The application utilizes advanced speech processing technology to analyze a patient's voice, allowing for near real-time monitoring and early detection of health deterioration. By transcribing patients' speech, the platform assists healthcare providers in identifying potential issues, enabling them to intervene before conditions worsen and prevent unnecessary hospitalizations. This innovative approach emphasizes patient well-being and aims to facilitate care management while allowing patients to remain at home.

Blue White Robotics specializes in transforming agriculture through autonomous technology. The company offers a comprehensive platform that enhances both air and ground robot fleets, enabling seamless management and optimization. By leveraging remote sensing and artificial intelligence, Blue White Robotics provides farmers with in-field data to improve productivity and farm economics. Their solutions aim to enhance efficiency and safety while delivering actionable insights that contribute to a return on investment from the outset. The company's focus is on facilitating the easy and safe adoption of autonomy in agriculture, ultimately helping growers maximize productivity and reduce operational costs.

BrainQ is a company founded in 2016 and headquartered in Jerusalem, Israel, that focuses on developing precision neurology therapies for individuals with neuro disorders. The company operates a neuro recovery platform that employs a brain-computer interface (BCI) approach to target damaged neuronal networks. By integrating machine learning algorithms with neuroscience, BrainQ extracts biological insights that inform the creation of tailored therapies. These innovations aim to facilitate neuro recovery and enhance the quality of life for patients, enabling them to live more independent and fulfilling lives.

Aleph Farms Limited, based in Ashdod, Israel, is a food technology company focused on sustainable animal product innovation through cellular agriculture. Founded in 2017, Aleph Farms has pioneered the development of lab-cultured meat, notably unveiling the world’s first cultivated thin-cut steak in 2018 and the first cultivated ribeye steak in 2021. The company utilizes proprietary three-dimensional bioprinting technology to grow animal products directly from non-genetically modified cells, thereby eliminating the need for animal slaughter. Under its product brand, Aleph Cuts, Aleph Farms is set to launch the Petit Steak, which is produced from premium Angus cow cells. The company has been recognized for its commitment to climate leadership and sustainability, receiving accolades from the World Economic Forum and the United Nations for its net zero commitment made in 2020.

Aleph Farms Limited, based in Ashdod, Israel, is a food technology company focused on sustainable animal product innovation through cellular agriculture. Founded in 2017, Aleph Farms has pioneered the development of lab-cultured meat, notably unveiling the world’s first cultivated thin-cut steak in 2018 and the first cultivated ribeye steak in 2021. The company utilizes proprietary three-dimensional bioprinting technology to grow animal products directly from non-genetically modified cells, thereby eliminating the need for animal slaughter. Under its product brand, Aleph Cuts, Aleph Farms is set to launch the Petit Steak, which is produced from premium Angus cow cells. The company has been recognized for its commitment to climate leadership and sustainability, receiving accolades from the World Economic Forum and the United Nations for its net zero commitment made in 2020.

KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment options for cancer and autoimmune disorders.

Ribon Therapeutics, Inc. is a biotechnology company based in Lexington, Massachusetts, focused on developing novel cancer therapies that target monoPARP proteins, which are essential regulators of cancer survival mechanisms. Established in 2015, Ribon is leveraging insights from its scientific founders and an experienced management team to create a proprietary drug discovery platform aimed at understanding the molecular actions and biological functions of monoPARPs. This platform enables the development of small molecule inhibitors designed to disrupt cancer cells' abilities to withstand stress, potentially leading to innovative treatments for cancer and other diseases. The company is supported by notable life science investors, positioning it for growth in the biopharmaceutical sector.

Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

OutSense develops an IoT medical device aimed at early illness detection and wellness monitoring through the analysis of human waste. Utilizing innovative imaging technologies, the device detects tiny quantities of blood mixed with stool directly within a standard toilet bowl. This capability allows for the generation of daily medical status reports for individuals, alerting caregivers to health deviations and potential abnormalities. The primary focus of OutSense is the prevention of colorectal cancer by identifying hidden blood in stool, a well-established screening method that traditionally requires sending samples to specialized laboratories. By integrating this technology with a mobile application, OutSense aims to enhance proactive health management and improve early diagnosis.

Blue White Robotics specializes in transforming agriculture through autonomous technology. The company offers a comprehensive platform that enhances both air and ground robot fleets, enabling seamless management and optimization. By leveraging remote sensing and artificial intelligence, Blue White Robotics provides farmers with in-field data to improve productivity and farm economics. Their solutions aim to enhance efficiency and safety while delivering actionable insights that contribute to a return on investment from the outset. The company's focus is on facilitating the easy and safe adoption of autonomy in agriculture, ultimately helping growers maximize productivity and reduce operational costs.

Hairstetics Ltd. is an innovative medical device company based in Omer, Israel, founded in 2010. The company specializes in the development, manufacturing, and marketing of advanced hair restoration devices. Hairstetics offers a range of solutions, including surgical hair transplantation and non-surgical methods, alongside customizable hair implantation services that allow for various colors, styles, and lengths. Their products are designed to simplify the hair implantation procedure, reduce recovery time, and deliver enhanced aesthetic results at a more affordable cost compared to traditional techniques. Through these offerings, Hairstetics aims to provide effective solutions for individuals experiencing hair loss.

Catheter procedure for LAA (left atrial appendage) closure, for Atrial fibrillation patients

Deploying the latest technologies Payzday is able to create unprecedented visibility into the risk level of merchants selling on marketplaces. Payzday goes much further than analyzing and predicting merchant behavior during the onboarding process analyzing past data. Payzday provides continuous monitoring to predict in near real time any unlawful, risky, or unstable situation of the Merchant.

Atrial Fibrillation treatment using cryo

Levation Pharma focuses on developing innovative treatments in aesthetic dermatology. The company is known for its topical oxymetazoline product, which is designed for cosmetic eye lifts. This product features a drying aqueous gel that utilizes a transdermal formulation of oxymetazoline. It specifically targets the treatment of droopy upper eyelids, medically referred to as ptosis or blepharoptosis. By enabling patients to raise their upper lids, this product not only enhances the visual fields but also improves the overall appearance of the eyes.

SinuSafe Medical, founded in 2014 and based in Tel Aviv, Israel, focuses on developing a nano-debrider device aimed at treating sinus-related issues without the need for surgical intervention. This innovative device allows for sinus irrigation and aspiration by implanting bone between the lining and the maxillary sinus, providing a non-invasive solution for patients suffering from chronic sinusitis. By enabling sinus lavage in a physician's office, SinuSafe Medical offers ear, nose, and throat (ENT) specialists a means to deliver immediate relief to their patients, thereby improving their quality of life.

Restore Medical is a medical device company focused on treating congestive heart failure, specifically targeting patients with left ventricle failure. Founded in 2016 and based in Or Yehuda, Israel, the company offers ContraBand, a catheter-delivered implant designed for placement in the pulmonary arteries. This innovative device aims to enhance left ventricle ejection fraction, decrease mitral regurgitation, and restore favorable ventricular geometry. By improving patient outcomes, Restore Medical's solutions contribute to a better quality of life and aim to reduce the rates of hospital readmission among affected individuals.

Raziel Health is a pharmaceutical company based in Rehovot, Israel, focused on developing innovative treatments for obesity and related fat disorders. The company's primary product, RZL-012, is a synthetic small molecule designed for injection into subcutaneous fat, where it induces fat cell death at the injection site, leading to a significant and long-lasting reduction in fat tissue. Raziel Health is actively conducting clinical trials to explore the efficacy of RZL-012 for various fat-related conditions, including Dercum's disease, as well as for aesthetic purposes. In addition to its pharmaceutical endeavors, Raziel Health aims to enhance healthcare accessibility by offering integrated technologies that promote timely clinical intervention and support individual patient wellness and disease management from the comfort of their homes.

Raziel Health is a pharmaceutical company based in Rehovot, Israel, focused on developing innovative treatments for obesity and related fat disorders. The company's primary product, RZL-012, is a synthetic small molecule designed for injection into subcutaneous fat, where it induces fat cell death at the injection site, leading to a significant and long-lasting reduction in fat tissue. Raziel Health is actively conducting clinical trials to explore the efficacy of RZL-012 for various fat-related conditions, including Dercum's disease, as well as for aesthetic purposes. In addition to its pharmaceutical endeavors, Raziel Health aims to enhance healthcare accessibility by offering integrated technologies that promote timely clinical intervention and support individual patient wellness and disease management from the comfort of their homes.

Magneto Thrombectomy is a medical device company focused on developing innovative thrombectomy devices for the treatment of ischemic stroke. Their technology employs electric attractive forces to facilitate the efficient and safe retrieval of various types of blood clots, ranging from large proximal to small distal locations within the vascular system. This method minimizes radial forces exerted on blood vessels, allowing access to the most distal regions of the brain. By enabling medical professionals to perform thrombectomy procedures effectively, Magneto Thrombectomy aims to optimize patient outcomes for those diagnosed with acute ischemic stroke.

Medical device company treating the mitral valve

Roby offers an artificial intelligence assistant for rental agencies and property managers. It an autonomous machine that requires only a few human interventions and is able to execute across all the different tasks involved in property management. Roby utilizes push notifications via SMS and email to invite users and their clients to engage with the rental process. It reduces manual tasks, streamlines workflow, improves compliance, and reduces costs.

Aleph Farms Limited, based in Ashdod, Israel, is a food technology company focused on sustainable animal product innovation through cellular agriculture. Founded in 2017, Aleph Farms has pioneered the development of lab-cultured meat, notably unveiling the world’s first cultivated thin-cut steak in 2018 and the first cultivated ribeye steak in 2021. The company utilizes proprietary three-dimensional bioprinting technology to grow animal products directly from non-genetically modified cells, thereby eliminating the need for animal slaughter. Under its product brand, Aleph Cuts, Aleph Farms is set to launch the Petit Steak, which is produced from premium Angus cow cells. The company has been recognized for its commitment to climate leadership and sustainability, receiving accolades from the World Economic Forum and the United Nations for its net zero commitment made in 2020.

mPharma is a company focused on improving access to affordable medications for patients in emerging markets. Established in 2013 by Gregory Rockson, Daniel Shoukimas, and James Finucane, mPharma collaborates with pharmaceutical manufacturers, health insurance providers, financial institutions, and governments to facilitate the direct delivery of prescription drugs to consumers. The company offers a pharmaceutical data analytics platform that assists pharmacies in managing their inventory effectively, ensuring that essential chronic disease medications are available at sustainable prices. By enabling doctors, patients, and pharmacists to connect with a network of high-quality medicines, mPharma aims to enhance the overall accessibility and affordability of healthcare for underserved populations.

Magnisity is a technology company founded in 2018 in Or Yehuda, Israel, by Benny Greenburg and Ron Barak. It specializes in developing innovative solutions for minimally invasive surgeries through a unique platform that integrates hardware design, software development, precise mechanics, and engineering. By leveraging advanced algorithms, Magnisity aims to enhance the capabilities of medical devices, enabling surgeons to address complex challenges in endoluminal interventions effectively. The company's focus on creating tools for both surgeons and patients positions it as a key player in the evolution of minimally invasive medicine.

Catheter procedure for LAA (left atrial appendage) closure, for Atrial fibrillation patients

Deploying the latest technologies Payzday is able to create unprecedented visibility into the risk level of merchants selling on marketplaces. Payzday goes much further than analyzing and predicting merchant behavior during the onboarding process analyzing past data. Payzday provides continuous monitoring to predict in near real time any unlawful, risky, or unstable situation of the Merchant.

Kymera Labs specializes in synthetic data generation through an innovative algebra-based mathematical model that ensures the preservation of statistical quality and data features while safeguarding actual data. The company's software allows clients to synthesize various data types, including scalars, labels, addresses, and dates, all while maintaining data dependencies and minimizing bias. This approach enables the generation of tailored synthetic data for different verticals, ensuring compliance with privacy laws and enhancing data utility. By offering a risk-free solution, Kymera Labs effectively addresses the challenges associated with data security and privacy in data-driven environments.

Magneto Thrombectomy is a medical device company focused on developing innovative thrombectomy devices for the treatment of ischemic stroke. Their technology employs electric attractive forces to facilitate the efficient and safe retrieval of various types of blood clots, ranging from large proximal to small distal locations within the vascular system. This method minimizes radial forces exerted on blood vessels, allowing access to the most distal regions of the brain. By enabling medical professionals to perform thrombectomy procedures effectively, Magneto Thrombectomy aims to optimize patient outcomes for those diagnosed with acute ischemic stroke.

Restore Medical Solutions is a medical device company focusing on products and techniques that promote SSI reduction, safety, and productivity within healthcare. The company manufactures a sterilization tray system that reduces the risk of infection from contaminated medical instruments. Its modular sterilization tray systems reduce the potential risk of infection from contaminated instruments and enable surgical departments to improve the quality of care while reducing cost. Founded in 2012, Restore Medical Solutions is headquartered in Memphis, Tennessee.

Atrial Fibrillation treatment using cryo

Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

CliClap LTD is a content marketing utility based in Kfar Saba, Israel, founded in 2016. The company offers an AI-powered platform designed to enhance audience engagement and brand visibility by tracking and optimizing shared content. Its solution supports businesses in generating leads and increasing traffic through effective content marketing strategies. By guiding visitors through personalized content journeys, CliClap helps nurture qualified leads without requiring extensive management. The platform integrates seamlessly with existing marketing automation, CRM, and social media management tools, allowing marketing teams to operate more efficiently and significantly boost conversion rates. Overall, CliClap aims to drive business goals by providing actionable insights and enhancing user interaction with content.

CliClap LTD is a content marketing utility based in Kfar Saba, Israel, founded in 2016. The company offers an AI-powered platform designed to enhance audience engagement and brand visibility by tracking and optimizing shared content. Its solution supports businesses in generating leads and increasing traffic through effective content marketing strategies. By guiding visitors through personalized content journeys, CliClap helps nurture qualified leads without requiring extensive management. The platform integrates seamlessly with existing marketing automation, CRM, and social media management tools, allowing marketing teams to operate more efficiently and significantly boost conversion rates. Overall, CliClap aims to drive business goals by providing actionable insights and enhancing user interaction with content.

DOKKA operates a cloud-based software platform designed to automate the invoice processing workflow for bookkeepers and accountants. Utilizing proprietary artificial intelligence and visual recognition technology, DOKKA streamlines the documentation process, significantly reducing the time and costs associated with manual data entry. The platform is compatible with a wide range of accounting systems, seamlessly integrating with both major ERP platforms and lesser-known systems. DOKKA's technology is particularly beneficial for small businesses and contractors, allowing them to enhance their accounting operations while minimizing errors. The deployment of the software typically takes between 7 to 14 days, offering both done-for-you and collaborative API integration options to accommodate various user needs.

Levation Pharma focuses on developing innovative treatments in aesthetic dermatology. The company is known for its topical oxymetazoline product, which is designed for cosmetic eye lifts. This product features a drying aqueous gel that utilizes a transdermal formulation of oxymetazoline. It specifically targets the treatment of droopy upper eyelids, medically referred to as ptosis or blepharoptosis. By enabling patients to raise their upper lids, this product not only enhances the visual fields but also improves the overall appearance of the eyes.

Deploying the latest technologies Payzday is able to create unprecedented visibility into the risk level of merchants selling on marketplaces. Payzday goes much further than analyzing and predicting merchant behavior during the onboarding process analyzing past data. Payzday provides continuous monitoring to predict in near real time any unlawful, risky, or unstable situation of the Merchant.

Cordio Medical LTD. is a company based in Or Yehuda, Israel, founded in 2013, that specializes in developing a mobile application aimed at monitoring patients with congestive heart failure. The application utilizes advanced speech processing technology to analyze a patient's voice, allowing for near real-time monitoring and early detection of health deterioration. By transcribing patients' speech, the platform assists healthcare providers in identifying potential issues, enabling them to intervene before conditions worsen and prevent unnecessary hospitalizations. This innovative approach emphasizes patient well-being and aims to facilitate care management while allowing patients to remain at home.

Cordio Medical LTD. is a company based in Or Yehuda, Israel, founded in 2013, that specializes in developing a mobile application aimed at monitoring patients with congestive heart failure. The application utilizes advanced speech processing technology to analyze a patient's voice, allowing for near real-time monitoring and early detection of health deterioration. By transcribing patients' speech, the platform assists healthcare providers in identifying potential issues, enabling them to intervene before conditions worsen and prevent unnecessary hospitalizations. This innovative approach emphasizes patient well-being and aims to facilitate care management while allowing patients to remain at home.

Digma Medical is a clinical stage medical device company revolutionizing the treatment of Type-2 Diabetes and other metabolic syndrome disease such as NASH. Founded in 2013 and backed by leading venture capital firms, Digma is dedicated to the development of the DiaGone™ to treat insulin resistance - the underlying mechanism of the disease. The DiaGone™ is an endoscopic, disposable device, that uses state of the art laser technology to treat the duodenum without an implant. The Duodenal Glycemic Control™ procedure is a one-time 30 minute GI procedure, in which the gastroenterologist uses the DiaGone™ to treat the duodenum for restoring the natural ability of the body to control glucose levels, which may provide long term remission from Type-2 Diabetes, NASH, and other metabolic syndrome related disease.

Rise.ai operates a strategic re-engagement platform that enables brands and retailers to utilize a unique currency system, including gift cards and store credits. By leveraging artificial intelligence, the company helps merchants enhance customer retention and boost average spending. The platform manages the entire re-engagement cycle, offering features such as loyalty cards, rewards, and refunds. Additionally, it allows users to send gifts, such as drinks and treats, to friends, thereby facilitating social gifting experiences. Through these services, Rise.ai aims to strengthen customer relationships and drive revenue growth for eCommerce agencies, brands, and merchants.

Eve Pharma is a preclinical drug delivery company focused on developing treatments for bacterial vaginosis, a condition commonly affecting women's health. Specializing in gynecology, the firm is working on a lead product designed to identify the source of vaginal infections, thereby facilitating easier diagnosis and treatment for healthcare providers. Through its innovative approach, Eve Pharma aims to enhance the clinical management of this condition, improving patient outcomes in the field of gynecological health.

OutSense develops an IoT medical device aimed at early illness detection and wellness monitoring through the analysis of human waste. Utilizing innovative imaging technologies, the device detects tiny quantities of blood mixed with stool directly within a standard toilet bowl. This capability allows for the generation of daily medical status reports for individuals, alerting caregivers to health deviations and potential abnormalities. The primary focus of OutSense is the prevention of colorectal cancer by identifying hidden blood in stool, a well-established screening method that traditionally requires sending samples to specialized laboratories. By integrating this technology with a mobile application, OutSense aims to enhance proactive health management and improve early diagnosis.

Magneto Thrombectomy is a medical device company focused on developing innovative thrombectomy devices for the treatment of ischemic stroke. Their technology employs electric attractive forces to facilitate the efficient and safe retrieval of various types of blood clots, ranging from large proximal to small distal locations within the vascular system. This method minimizes radial forces exerted on blood vessels, allowing access to the most distal regions of the brain. By enabling medical professionals to perform thrombectomy procedures effectively, Magneto Thrombectomy aims to optimize patient outcomes for those diagnosed with acute ischemic stroke.

NeuroApplied Ltd. is a marketing research company based in Hadera, Israel, founded in June 2016. The firm specializes in customer-focused marketing by exploring the collective subconscious of consumers. Utilizing machine-learning analytics and neural-network computing, NeuroApplied's platform incorporates online picture games to collect data that reflects customers' associative subconscious responses. This SaaS-based platform features an intuitive dashboard that presents insights in a visually engaging and nonintrusive manner. The services offered include brand equity assessment, tracking of brand properties, crisis management, and decision support, all designed to help brand managers understand and quantify consumer perceptions effectively.

Eximo Medical Ltd. is an Israeli company specializing in hybrid catheter technology aimed at improving tissue resection in vascular and gastrointestinal endoluminal applications. Founded in 2012 and based in Modi'in-Maccabim-Re'ut, the company has developed the CatHI™, a proprietary single-use hybrid catheter that integrates optical fibers for delivering short laser pulses with a blunt mechanical knife. This innovative design enhances the safety and effectiveness of procedures, particularly in lead extraction and the treatment of peripheral artery disease, by minimizing the risk of vessel perforation. As of October 2019, Eximo Medical operates as a subsidiary of AngioDynamics, Inc.

Restore Medical Solutions is a medical device company focusing on products and techniques that promote SSI reduction, safety, and productivity within healthcare. The company manufactures a sterilization tray system that reduces the risk of infection from contaminated medical instruments. Its modular sterilization tray systems reduce the potential risk of infection from contaminated instruments and enable surgical departments to improve the quality of care while reducing cost. Founded in 2012, Restore Medical Solutions is headquartered in Memphis, Tennessee.

mPharma is a company focused on improving access to affordable medications for patients in emerging markets. Established in 2013 by Gregory Rockson, Daniel Shoukimas, and James Finucane, mPharma collaborates with pharmaceutical manufacturers, health insurance providers, financial institutions, and governments to facilitate the direct delivery of prescription drugs to consumers. The company offers a pharmaceutical data analytics platform that assists pharmacies in managing their inventory effectively, ensuring that essential chronic disease medications are available at sustainable prices. By enabling doctors, patients, and pharmacists to connect with a network of high-quality medicines, mPharma aims to enhance the overall accessibility and affordability of healthcare for underserved populations.

SinuSafe Medical, founded in 2014 and based in Tel Aviv, Israel, focuses on developing a nano-debrider device aimed at treating sinus-related issues without the need for surgical intervention. This innovative device allows for sinus irrigation and aspiration by implanting bone between the lining and the maxillary sinus, providing a non-invasive solution for patients suffering from chronic sinusitis. By enabling sinus lavage in a physician's office, SinuSafe Medical offers ear, nose, and throat (ENT) specialists a means to deliver immediate relief to their patients, thereby improving their quality of life.

mPharma is a company focused on improving access to affordable medications for patients in emerging markets. Established in 2013 by Gregory Rockson, Daniel Shoukimas, and James Finucane, mPharma collaborates with pharmaceutical manufacturers, health insurance providers, financial institutions, and governments to facilitate the direct delivery of prescription drugs to consumers. The company offers a pharmaceutical data analytics platform that assists pharmacies in managing their inventory effectively, ensuring that essential chronic disease medications are available at sustainable prices. By enabling doctors, patients, and pharmacists to connect with a network of high-quality medicines, mPharma aims to enhance the overall accessibility and affordability of healthcare for underserved populations.

Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

Evolero is an event & conference management software that’s a one-stop-platform. It offers all online services and tools for conference planning and organizing. Sell your tickets online, manage your event ticketing and registration, offer your sponsors advanced marketing tools and your attendees powerful networking tools – all in one place. Evolero offers meeting planners and congress organizers the most up-to-date conference management, with a social twist!

ShapeDo Ltd. is a software company based in Modi'in-Maccabim-Re'ut, Israel, founded in 2014. It specializes in developing solutions to manage the implications of plan changes in construction projects. The company's cloud-based platform facilitates end-to-end management of these changes by organizing blueprints, comparing versions, and ensuring that all modifications are reflected in contracts, budgets, and agreements. ShapeDo's software aids in creating court-ready pricing reports, requests for information, and claims. The company has been involved in significant infrastructure projects, including airports, underground trains, hospitals, and data centers, and its solutions are also applicable to smaller commercial and residential projects.

Cordio Medical LTD. is a company based in Or Yehuda, Israel, founded in 2013, that specializes in developing a mobile application aimed at monitoring patients with congestive heart failure. The application utilizes advanced speech processing technology to analyze a patient's voice, allowing for near real-time monitoring and early detection of health deterioration. By transcribing patients' speech, the platform assists healthcare providers in identifying potential issues, enabling them to intervene before conditions worsen and prevent unnecessary hospitalizations. This innovative approach emphasizes patient well-being and aims to facilitate care management while allowing patients to remain at home.

Yotta is the first-of-its-kind smart home system that enhances energy efficiency and comfort and provides safety services based on household behavior. Yotta's proprietary breakthrough technologies monitor and measure household power consumption and learn consumer usage patterns. Once the system understands the behavioral patterns of the household, it transforms abnormal electrical behavior into useful insights and reacts appropriately: for instance, alerting the consumers to potential energy waste or electrical hazards or fires; turning off lights and appliances that are not in use, or even lowering blinds before an upcoming storm. These services are provided through a user-friendly smart phone app as well as touch and gesture activation devices that allow for maximum convenience and comfort.

NitiNotes is a company specializing in innovative medical technology, particularly for the field of gastroenterology. It has developed the EndoZip™, a fully automated gastroscopic suturing system designed to enhance the safety and simplicity of gastrointestinal suturing. This minimally invasive device enables gastroenterologists and surgeons to perform procedures that mimic laparoscopic sleeve gastrectomy, effectively creating a stomach volume restriction to assist patients with obesity in achieving weight loss. The system is intended for patients classified as obesity class I and II, providing an alternative for those who may not qualify for traditional bariatric surgery. By streamlining endoscopic gastroplasty procedures, NitiNotes aims to make effective weight-loss treatments more accessible to a broader range of patients.

Jobrain Ltd. is a Herzliya, Israel-based company that offers a cloud-based hiring software designed to streamline the recruitment process for HR professionals. The platform allows candidates to easily apply for jobs using mobile devices, while HR teams can quickly identify and hire the best talent. Jobrain provides an open marketplace that includes various talent acquisition services such as job post distribution, remote interviews, one-way video interviews, and candidate assessments. Additionally, it features a job search application that connects users to a network of recruiters, utilizing machine learning to match candidates with over 100,000 job opportunities worldwide, primarily in software development and small startups. By leveraging data science, Jobrain simplifies the hiring process, enabling clients to focus on essential tasks rather than administrative burdens.

Zuznow is a mobile application development company that specializes in adapting complex websites for optimal use on smartphones. Founded in 2009 and based in Israel, Zuznow's platform automatically analyzes the visual structure of desktop websites and transforms them for mobile devices. This capability allows businesses to implement effective mobile strategies for various applications, including B2B, B2C, and B2E. The platform streamlines the development process, enabling organizations to create secure mobile applications while significantly reducing time to market and lowering costs associated with setup and maintenance. Zuznow's clientele includes notable companies such as VentureBeat, HOOP, Newsgeek, and Baker Tilly.

Marketyze is a technology company that offers semantic site search and online price comparison solutions ground on deep domain expertise. Catering to the retail industry, the company’s pricing intelligence software tracks and analyzes pricing, and market and internal data to discover how pricing events can affect company sales performance. This in turn empowers companies to fine tune their pricing policies to maximize both sales and profits. Marketyze was founded by Onn Manelson and Nave Ronen in December 2011 and is based in Israel.

Evolero is an event & conference management software that’s a one-stop-platform. It offers all online services and tools for conference planning and organizing. Sell your tickets online, manage your event ticketing and registration, offer your sponsors advanced marketing tools and your attendees powerful networking tools – all in one place. Evolero offers meeting planners and congress organizers the most up-to-date conference management, with a social twist!

ArTack Medical is a privately held medical device company that develops tools for the invasive surgery market. The tools are based on ArTack Medical's patented drive platform, which allows the delivery of torque through a 5mm shaft. ArTack Medical was founded on 2013 and is headquartered in Haifa, Israel.

Mend (previously known as WhiteSource) founded in 2011, Mend is the first application security platform that actually automates the process of fixing application vulnerabilities. Mend takes most of the burden off the developer, who doesn’t really need to become a security expert. That’s why our motto is: You code, we cure. Mend is used by more than 1000 customers worldwide, from all verticals and sizes, including 23% of Fortune 100 companies, as well as industry leaders such as Microsoft, IBM, Comcast, and many more. For more information, please visit www.mend.io

CartiHeal is a medical device company based in Kfar Sava, Israel, specializing in cartilage and bone regeneration. Founded in 2009, the company has developed the Agili-C implant, a cell-free and off-the-shelf solution designed to address focal articular cartilage and osteochondral defects. This innovative implant promotes the regeneration of hyaline cartilage and the underlying subchondral bone without the need for cells or growth factors, making it a significant advancement in the treatment of cartilage injuries. Given the limited natural healing capacity of hyaline cartilage, CartiHeal's technology offers a promising option for patients suffering from cartilage damage, which can lead to severe pain and disability if untreated. The Agili-C implant can be inserted using arthroscopic or minimally invasive techniques, facilitating faster rehabilitation and enhanced recovery outcomes for patients.

CardioGard develops a specially designed arterial cannula for the removal of gaseous material during heart bypass surgeries. The system is composed of a double-lumen cannula in which the primary lumen provides oxygenated blood from the heart-lung machine to the patient and a secondary lumen suctions blood and embolic matter away from the surgical field and back to the cardiopulmonary bypass machine for the filtration.

Eximo Medical Ltd. is an Israeli company specializing in hybrid catheter technology aimed at improving tissue resection in vascular and gastrointestinal endoluminal applications. Founded in 2012 and based in Modi'in-Maccabim-Re'ut, the company has developed the CatHI™, a proprietary single-use hybrid catheter that integrates optical fibers for delivering short laser pulses with a blunt mechanical knife. This innovative design enhances the safety and effectiveness of procedures, particularly in lead extraction and the treatment of peripheral artery disease, by minimizing the risk of vessel perforation. As of October 2019, Eximo Medical operates as a subsidiary of AngioDynamics, Inc.

Valire is a software solution company that specializes in the field of artificial intelligence. It features fraud risk assessment, business process validation, and algorithm development that helps businesses, companies, and organizations to secure their revenue. The company was founded in 2009 and headquartered in HaMerkaz, Israel.

QuickLizard is an AI-powered technology provider specializing in dynamic pricing solutions for retailers and direct-to-consumer brands. The company offers a comprehensive platform that enables users to manage their pricing strategies effectively, featuring tools, insights, and analytics aimed at driving business growth and profitability. QuickLizard serves a wide array of retail sectors, including consumer electronics, beauty, home goods, sporting equipment, apparel, pet supplies, groceries, and airlines. Its platform operates in over 40 markets, seamlessly integrating both online and offline sales channels, and generates hundreds of millions of pricing recommendations each month.

Otic Pharma is a clinical-stage pharmaceutical company focusing on the development and commercialization of products for disorders of the ear, nose, and throat (ENT). The company has two platform technologies, each of which has the potential to be developed for multiple ENT indications. The company is currently developing a nasally-administered, combination drug product (OP-02) intended to address the underlying cause of otitis media and Eustachian tube dysfunction (OM/ETD), a condition that affects more than 700 million people around the world every year. Otitis media is one of the most common disease seen in pediatric practice and the most frequent reason children consume antibiotics or undergo surgery. The company also has a foam-based drug delivery technology platform (OP-01) that can be used to deliver drugs into the ear, nose, and sinus cavities. The company is currently developing OP-01 as an improved treatment option for acute otitis externa (“swimmers ear”). For more information on the company, please visit www.oticpharma.com

Rocketick Technologies is a software development company founded in 2008 by experts in hardware-assisted acceleration. It specializes in GPU-based simulation acceleration for chip verification, addressing functional verification bottlenecks in the semiconductor industry. Its flagship product, RocketSim, enhances traditional simulators by providing a GPU-based acceleration solution, achieving up to ten times faster simulations for complex chip designs. This innovative approach helps chip manufacturers reduce the overall time to market for new designs, making Rocketick a valuable partner for several semiconductor clients.

CartiHeal is a medical device company based in Kfar Sava, Israel, specializing in cartilage and bone regeneration. Founded in 2009, the company has developed the Agili-C implant, a cell-free and off-the-shelf solution designed to address focal articular cartilage and osteochondral defects. This innovative implant promotes the regeneration of hyaline cartilage and the underlying subchondral bone without the need for cells or growth factors, making it a significant advancement in the treatment of cartilage injuries. Given the limited natural healing capacity of hyaline cartilage, CartiHeal's technology offers a promising option for patients suffering from cartilage damage, which can lead to severe pain and disability if untreated. The Agili-C implant can be inserted using arthroscopic or minimally invasive techniques, facilitating faster rehabilitation and enhanced recovery outcomes for patients.

Cellvine develops and markets innovative coverage and capacity solutions for the wireless telecommunications industry. Cellvine's broad range of cellular coverage enhancement products and solutions are based on its exclusive technology for improving cellular signals for in-building, urban and rural over-ground and subterranean environments such as mines and tunnels.

CardioNova is a biotechnology company focused on developing medical solutions for cardiovascular diseases. The company specializes in creating drugs designed to treat conditions such as atrial fibrillation and dyslipidemia, with the goal of preventing atherosclerosis. By providing innovative therapies, CardioNova aims to enable healthcare providers to achieve clinical objectives efficiently and cost-effectively.

Valtech Cardio (Israel) a development-stage medical device company focused on minimally invasive percutaneous annuloplasty ring valve repair for the treatment of mitral valve regurgitation.

Kailight Photonics develops optical modules for the telecommunications industry. It offers tunable optical signal regenerator, an optical component that operates with regenerators, optical switches, add/drop multiplexers, and cross-connects. The company's optical transmission, signal regeneration, and wavelength conversion technology provides optical-networking solutions for systems vendors. It provides its products to long-haul network market segments. The company, formerly known as Chilight Technologies, was founded in 2000 and is headquartered in Rehovot, Israel with an additional office in Dallas, Texas. As of May 15, 2007, Kailight Photonics, Inc. operates as a subsidiary of Optium Corporation.

TopSpin Medical developed an innovative and unique technology for high-resolution MRI using an IntraVascular MRI (IVMRI) catheter for the coronary arteries, without the need for an expensive and bulky external MRI setup. The catheter contains those components, which are usually found in a conventional MRI scanner, only that they are miniaturized to less than 2 millimeters in size.

VisionCare Ophthalmic Technologies, Inc., a Saratoga, CA-based developer of advanced visual prosthetic devices designed to improve vision in patients with end-stage age-related macular degeneration (AMD). VisionCare Ophthalmic Technologies (VisionCare) is a privately held specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders. Our lead product, the Implantable Miniature Telescope (by Dr. Isaac Lipshitz), is the first FDA-approved implantable medical device demonstrated to improve vision and quality of life in individuals with the most advanced, irreversible form of age-related macular degeneration (AMD) – End-Stage AMD. End-Stage AMD is the leading cause of blindness in older Americans. The telescope implant is integral to the CentraSight™ treatment program which has been developed to help patients follow the necessary steps for proper diagnosis, surgical evaluation, and postoperative care. Our goal is to help patients reconnect to the things in life they love to see and do. To help achieve this, we will establish a high level of collaboration with our healthcare provider customers through a broad range of direct support programs and services.